CHIARINI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 733
NA - Nord America 726
AS - Asia 358
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.819
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 724
IT - Italia 227
HK - Hong Kong 217
SE - Svezia 160
GB - Regno Unito 146
CN - Cina 72
LT - Lituania 52
DE - Germania 42
FI - Finlandia 36
ID - Indonesia 33
IE - Irlanda 30
SG - Singapore 29
NL - Olanda 11
FR - Francia 7
BG - Bulgaria 4
CZ - Repubblica Ceca 4
UA - Ucraina 4
ES - Italia 3
RU - Federazione Russa 3
TR - Turchia 3
CA - Canada 2
RO - Romania 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
IN - India 1
JP - Giappone 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
Totale 1.819
Salva come PNG Salva come JPEG
Città #
Ashburn 266
Hong Kong 216
Nyköping 145
Chandler 58
Fairfield 56
London 42
Houston 37
Jakarta 33
Helsinki 32
Woodbridge 32
Dublin 30
Southend 30
Parma 29
Shanghai 21
Milan 20
Bologna 19
Cambridge 19
Beijing 18
Seattle 17
Singapore 16
Wilmington 16
Reggio Emilia 13
Modena 12
Munich 12
Washington 12
Kilburn 11
Padova 10
Amsterdam 9
Chiswick 9
Rome 9
Ann Arbor 8
Assago 8
New York 8
San Diego 8
Hounslow 7
Islington 7
Naples 7
Torre del Greco 7
Ferrara 6
Glasgow 6
Carpi 5
Dearborn 5
Frankfurt am Main 5
Arceto 4
Brno 4
Jacksonville 4
Prescot 4
Princeton 4
Sofia 4
Boardman 3
Catania 3
Eugene 3
Guangzhou 3
Lappeenranta 3
Los Angeles 3
Perugia 3
Southwark 3
Venice 3
Aberdare 2
Brentford 2
Chicago 2
Curtatone 2
Dong Ket 2
Falls Church 2
Frattamaggiore 2
Giuliano di Roma 2
Gualtieri 2
Izmir 2
La Spezia 2
Madrid 2
Montecatini Terme 2
Paris 2
Pescara 2
Portici 2
Ravenna 2
Roncoferraro 2
Stockholm 2
Turin 2
Urbino 2
Wandsworth 2
Wuhan 2
Acton 1
Andover 1
Auckland 1
Bilbao 1
Bonn 1
Bonndorf 1
Bremen 1
Brescello 1
Brunico 1
Bucharest 1
Cedar Knolls 1
Central 1
Chisinau 1
Chiyoda-ku 1
Chongqing 1
Dongyang 1
Edinburgh 1
Fremont 1
Galati 1
Totale 1.452
Salva come PNG Salva come JPEG
Nome #
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 200
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: Turning offthe prosurvival ER chaperone BIP/Grp78 and turning on the proapoptotic NF-κB 134
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer 125
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance 78
The Combination of AHCC and ETAS Decreases Migration of Colorectal Cancer Cells, and Reduces the Expression of LGR5 and Notch1 Genes in Cancer Stem Cells: A Novel Potential Approach for Integrative Medicine 58
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma 49
Targeting metabolic vulnerabilities and aberrant signal transduction pathways in paediatric T-cell Acute Lymphoblastic Leukaemia (T-ALL) 41
Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK) 29
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells 28
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications 25
Understanding the Roles of the Hedgehog Signaling Pathway during T-Cell Lymphopoiesis and in T-Cell Acute Lymphoblastic Leukemia (T-ALL) 25
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 24
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 24
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression 22
Assessment of the structural and functional characteristics of human mesenchymal stem cells associated with a prolonged exposure of morphine 21
Cellular senescence in vascular wall mesenchymal stromal cells, a possible contribution to the development of aortic aneurysm 20
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia 20
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 20
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia 20
B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients? 20
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 19
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting 19
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients 19
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107) 19
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines 18
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia 18
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS 18
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia 18
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment 18
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia 17
13. PLCβ1a and PLCβ1b selective regulation and cyclin D3 modulation reduced by kinamycin F during k562 cell differentiation 17
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications 17
Implication of Cellular Senescence in Osteoarthritis: A Study on Equine Synovial Fluid Mesenchymal Stromal Cells 17
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors 17
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 16
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels 16
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy 16
Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics 16
Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a 16
The emerging role of the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in normal myelopoieis and leukemogenesis 16
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance 15
Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML 15
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes 15
Age-Related Alterations Affecting the Chondrogenic Differentiation of Synovial Fluid Mesenchymal Stromal Cells in an Equine Model 14
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells 14
Targeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells 13
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 13
Therapeutic targeting of CK2 in acute and chronic leukemias 13
Pathobiology and Therapeutic Relevance of GSK-3 in Chronic Hematological Malignancies 13
Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update 12
Lamin A and Prelamin A Counteract Migration of Osteosarcoma Cells 12
K562 cell proliferation is modulated by PLCβ1 through a PKCα-mediated pathway 12
Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells 12
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway 12
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation 12
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside 12
Phospholipase C-β1 interacts with cyclin E in adipose- derived stem cells osteogenic differentiation 12
Targeting the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in acute myelogenous leukaemia 11
Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia 11
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies 11
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 11
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia 10
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia 10
The Cutting Edge: The Role of mTOR Signaling in Laminopathies 10
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia 10
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 10
Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene 10
MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia 10
Pediatric early T-cell precursor leukemia with NF1 deletion and high-sensitivity in vitro to tipifarnib 10
The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic Leukemia 9
Dual inhibition of class IA phoshatidylinositol 3-kinase and mTOR as a new therapeutic option for T-cell acute lymphoblastic leukemia 9
GSK-3: a multifaceted player in acute leukemias 9
Current treatment strategies for inhibiting mTOR in cancer 9
Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment 9
Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients 9
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage 9
PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: new options for targeted therapy 9
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies 8
Temsirolimus, An Allosteric mTORC1 Inhibitor, Is Synergistic with Clofarabine in AML and AML Leukemia Initiating Cells 8
The Unfolded Protein Response: A Novel Therapeutic Target in Acute Leukemias 8
The Emerging Role of the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology 8
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review) 8
Dual Inhibition of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin: a Therapeutic Strategy for Acute Leukemias 8
New advances in targeting aberrant signaling pathways in T-cell acute lymphoblastic leukemia 7
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resisten human T-acute leukemia cells by a JNK-dependent mechanism 7
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms 6
Advances in Targeting Signal Transduction Pathways 6
The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis 6
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells 6
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia 6
Totale 1.839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.378
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202091 8 1 1 4 10 14 14 10 8 7 7 7
2020/2021132 8 5 10 14 5 19 12 15 10 7 14 13
2021/202290 3 6 4 13 2 4 8 7 8 7 18 10
2022/2023551 7 11 12 27 42 70 30 62 102 26 59 103
2023/2024909 35 28 42 150 125 66 177 62 26 28 87 83
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 1.839